Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial
Title:
Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial
Author:
Borys, Dorota Smulders, Ronald Haranaka, Miwa Nakano, Takashi Chichili, Gurunadh R. Ebara, Masaki Hashimoto, Atsuki Iwahana, Mioko Oizumi, Yuki Nanra, Jasdeep Malley, Richard Sebastian, Shite